Recent and potential developments of biofluid analyses in metabolomics

Journal of Proteomics

Volumn 75, Issue 4, 2012, Pages 1079-1088

  Zhang, Aihua ^a   Sun, Hui ^a   Wang, Ping ^a   Han, Ying ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biofluid analyses; Biomarkers; Disease diagnostics; Metabolites; Metabolomics; System biology

Indexed keywords

BODY FLUID; CEREBROSPINAL FLUID; HUMAN; METABOLOMICS; NONHUMAN; PLASMA; PRIORITY JOURNAL; REVIEW; SALIVA; SPERM; SYNOVIAL FLUID; TISSUE HOMOGENATE; URINALYSIS; URINE;

ANIMALS; BIOLOGICAL MARKERS; BODY FLUIDS; EQUIPMENT DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; METABOLOMICS; RESEARCH DESIGN;

EID: 84855883877     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.10.027     Document Type: Review

References (112)

1. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
2. Arakaki A.K., Skolnick J., McDonald J.F. Marker metabolites can be therapeutic targets as well. Nature 2008, 456:443.
3. de la Luz-Hernández K.R., Rojas-del Calvo L., Rabasa-Legón Y., Lage-Castellanos A., Castillo-Vitlloch A., Díaz J., et al. Metabolic and proteomic study of NS0 myeloma cell line following the adaptation to protein-free medium. J Proteomics 2008, 71:133-147.
4. Ryan D., Robards K., Prenzler P.D., Kendall M. Recent and potential developments in the analysis of urine: a review. Anal Chim Acta 2011, 684:8-20.
5. Koulman A., Lane G.A., Harrison S.J., Volmer D.A. From differentiating metabolites to biomarkers. Anal Bioanal Chem 2009, 394:663-670.
6. Nicholson J.K., Wilson I.D. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev 2003, 2:668-676.
7. Vallejo M., García A., Tuñón J., García-Martínez D., Angulo S., Martin-Ventura J.L., et al. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal Bioanal Chem 2009, 394:1517-1524.
8. Enea C., Seguin F., Petitpas-Mulliez J., Boildieu N., Boisseau N., Delpech N., et al. (1)H NMR-based metabolomics approach for exploring urinary metabolome modifications after acute and chronic physical exercise. Anal Bioanal Chem 2010, 396:1167-1176.
9. Cao B., Aa J., Wang G., Wu X., Liu L., Li M., et al. GC-TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization. Anal Bioanal Chem 2011, 400:2983-2993.
10. Kuhara T., Ohse M., Inoue Y., Cooper A.J. A GC/MS-based metabolomic approach for diagnosing citrin deficiency. Anal Bioanal Chem 2011, 400:1881-1894.
11. Johnson C.H., Patterson A.D., Krausz K.W., Lanz C., Kang D.W., Luecke H., et al. Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res 2011, 175:473-484.
12. Keun H.C., Athersuch T.J. Nuclear magnetic resonance (NMR)-based metabolomics. Methods Mol Biol 2011, 708:321-334.
13. Amantonico A., Urban P.L., Zenobi R. Analytical techniques for single-cell metabolomics: state of the art and trends. Anal Bioanal Chem 2010, 398:2493-2504.
14. Xu J., Yang S., Cai S., Dong J., Li X., Chen Z. Identification of biochemical changes in lactovegetarian urine using 1H NMR spectroscopy and pattern recognition. Anal Bioanal Chem 2010, 396:1451-1463.
15. Antonucci R., Atzori L., Barberini L., Fanos V. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine. Minerva Pediatr 2010, 62:145-148.
16. Vineis P., Khan A.E., Vlaanderen J., Vermeulen R. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health 2003, 8:54.
17. Workentine M.L., Harrison J.J., Weljie A.M., Tran V.A., Stenroos P.U., Tremaroli V., et al. Phenotypic and metabolic profiling of colony morphology variants evolved from Pseudomonas fluorescens biofilms. Environ Microbiol 2010, 12:1565-1577.
18. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
19. Hines A., Staff F.J., Widdows J., Compton R.M., Falciani F., Viant M.R. Discovery of metabolic signatures for predicting whole organism toxicology. Toxicol Sci 2010, 115:369-378.
20. Wang J., Reijmers T., Chen L., Van Der Heijden R., Wang M., Peng S., et al. Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics 2009, 5:407-418.
21. Pexa A., Boeger R.H., Henle T., Schwedhelm E., Deussen A. Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats. Br J Nutr 2009, 99:993-999.
22. Astle J., Ferguson J.T., German J.B., Harrigan G.G., Kelleher N.L., Kodadek T., et al. Characterization of proteomic and metabolomic responses to dietary factors and supplements. J Nutr 2007, 137:2787-2793.
23. Lee R., West D., Phillips S.M., Britz-McKibbin P. Differential metabolomics for quantitative assessment of oxidative stress with strenuous exercise and nutritional intervention: thiol-specific regulation of cellular metabolism with N-acetyl-L-cysteine pretreatment. Anal Chem 2010, 82:2959-2968.
24. Urakami K., Zangiacomi V., Yamaguchi K., Kusuhara M. Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed Res 2010, 31:161-163.
25. Tohge T., Fernie A.R. Combining genetic diversity, informatics and metabolomics to facilitate annotation of plant gene function. Nat Protoc 2010, 5:1210-1227.
26. Pluskal T., Nakamura T., Villar-Briones A., Yanagida M. Metabolic profiling of the fission yeast S. pombe: quantification of compounds under different temperatures and genetic perturbation. Mol Biosyst 2010, 6:182-198.
27. Clayton T.A., Lindon J.C., Cloarec O., Antti H., Charuel C., Hanton G., et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440:1073-1077.
28. Nomura D.K., Dix M.M., Cravatt B.F. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 2010, 10:630-638.
29. Wu H., Xue R., Tang Z., Deng C., Liu T., Zeng H., et al. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal Bioanal Chem 2010, 396:1385-1395.
30. Holmes E., Loo R.L., Stamler J., Bictash M., Yap I.K., Chan Q., et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453:396-401.
31. Cascante M., Benito A., Zanuy M., Vizán P., Marín S., de Atauri P. Metabolic network adaptations in cancer as targets for novel therapies. Biochem Soc Trans 2010, 38:1302-1306.
32. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
33. Wang H., Ma C., Ma L., Du Z., Wang H., Ye H., et al. Secondary metabolic profiling and artemisinin biosynthesis of two genotypes of Artemisia annua. Planta Med 2009, 75:1625-1633.
34. Fukushima A., Kusano M., Nakamichi N., Kobayashi M., Hayashi N., Sakakibara H., et al. Impact of clock-associated Arabidopsis pseudo-response regulators in metabolic coordination. Proc Natl Acad Sci U S A 2009, 106:7251-7256.
35. Catchpole G.S., Beckmann M., Enot D.P., Mondhe M., Zywicki B., Taylor J., et al. Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc Natl Acad Sci U S A 2009, 102:14458-14462.
36. Kim S.H., Yang S.O., Kim H.S., Kim Y., Park T., Choi H.K. 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem 2009, 395:1117-1124.
37. Sysi-Aho M., Ermolov A., Gopalacharyulu P.V., Tripathi A., Seppänen-Laakso T., Maukonen J., et al. Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol. 2011, 7:e1002257.
38. Jian W.X., Yuan Z.K., Huang X.P. Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010, 30:579-584.
39. Lawaetz A.J., Schmidt B., Staerk D., Jaroszewski J.W., Bro R. Application of rotated PCA models to facilitate interpretation of metabolite profiles: commercial preparations of St. John's Wort. Planta Med 2009, 75:271-279.
40. Kim H.K., Wilson E.G., Choi Y.H., Verpoorte R. Metabolomics: a tool for anticancer lead-finding from natural products. Planta Med 2010, 76:1094-1102.
41. Zhang A., Sun H., Wang Z., Sun W., Wang P., Wang X. Metabolomics: towards understanding traditional Chinese medicine. Planta Med 2010, 76:2026-2035.
42. Wang X., Sun H., Zhang A., Sun W., Wang P., Wang Z. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 2010, 55:859-868.
43. Barbas C., Moraes E.P., Villaseñor A. Capillary electrophoresis as a metabolomics tool for non-targeted fingerprinting of biological samples. J Pharm Biomed Anal 2011, 55:823-831.
44. Wang H., Tso V.K., Slupsky C.M., Fedorak R.N. Metabolomics and detection of colorectal cancer in humans: a systematic review. Future Oncol 2010, 6:1395-1406.
45. Kussmann M., Raymond F., Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006, 124:758-787.
46. Ooga T., Sato H., Nagashima A., Sasaki K., Tomita M., Soga T., et al. Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol Biosyst 2011, 7:1217-1223.
47. Winder C.L., Cornmell R., Schuler S., Jarvis R.M., Stephens G.M., Goodacre R. Metabolic fingerprinting as a tool to monitor whole-cell biotransformations. Anal Bioanal Chem 2011, 399:387-401.
48. Tong X., Sun H., Yan G.L., Dong W., Sun W.J., Yu Y., et al. Evaluation study on urine metabolomics in yinhuang rat model induced by triplet factors of rhubarb, ethanol, and α-nephthylisothiolyanate. Chin J Integr Med 2011, 17:369-375.
49. Kortz L., Helmschrodt C., Ceglarek U. Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids. Anal Bioanal Chem 2011, 399:2635-2644.
50. De Meyer T., Sinnaeve D., Van Gasse B., Rietzschel E.R., De Buyzere M.L., Langlois M.R., et al. Evaluation of standard and advanced preprocessing methods for the univariate analysis of blood serum 1H-NMR spectra. Anal Bioanal Chem 2010, 398:1781-1790.
51. Bujak R., Daghir E., Rybka J., Koslinski P., Markuszewski M.J. Metabolomics in urogenital cancer. Bioanalysis 2011, 3:913-923.
52. Patterson A.D., Bonzo J.A., Li F., Krausz K.W., Eichler G.S., Aslam S., et al. Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem 2011, 286:19511-19522.
53. Connor S.C., Hansen M.K., Corner A., Smith R.F., Ryan T.E. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst 2010, 6:909-921.
54. McClay J.L., Adkins D.E., Isern N.G., O'Connell T.M., Wooten J.B., Zedler B.K., et al. (1)H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function. J Proteome Res 2010, 9:3083-3090.
55. Taylor S.L., Ganti S., Bukanov N.O., Chapman A., Fiehn O., Osier M., et al. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol 2010, 298:909-922.
56. Nam H., Chung B.C., Kim Y., Lee K., Lee D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics 2009, 25:3151-3157.
57. Kim K., Aronov P., Zakharkin S.O., Anderson D., Perroud B., Thompson I.M., et al. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 2009, 8:558-570.
58. Serkova N.J., Glunde K. Metabolomics of cancer. Methods Mol Biol 2009, 520:273-295.
59. Jung J.Y., Lee H.S., Kang D.G., Kim N.S., Cha M.H., Bang O.S., et al. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 2011, 42:1282-1288.
60. Mattarucchi E., Baraldi E., Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed Chromatogr 2011, 10.1002/bmc.1631.
61. Kotłowska A., Sworczak K., Stepnowski P. Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879:359-363.
62. Otter D., Cao M., Lin H.M., Fraser K., Edmunds S., Lane G., et al. Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics. J Biomed Biotechnol 2011, 2011:974701.
63. Bonzo J.A., Patterson A.D., Krausz K.W., Gonzalez F.J. Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo. Mol Endocrinol 2010, 24:2343-2355.
64. Manna S.K., Patterson A.D., Yang Q., Krausz K.W., Li H., Idle J.R., et al. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res 2010, 9(8):4176-4188.
65. Llorach R., Garrido I., Monagas M., Urpi-Sarda M., Tulipani S., Bartolome B., et al. Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols. J Proteome Res 2010, 9:5859-5867.
66. Miccheli A., Marini F., Capuani G., Miccheli A.T., Delfini M., Di Cocco M.E., et al. The influence of a sports drink on the postexercise metabolism of elite athletes as investigated by NMR-based metabolomics. J Am Coll Nutr 2009, 28(5):553-564.
67. Llorach R., Urpi-Sarda M., Jauregui O., Monagas M., Andres-Lacueva C. An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. J Proteome Res 2009, 8:5060-5068.
68. Dai Y., Li Z., Xue L., Dou C., Zhou Y., Zhang L., et al. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress. J Ethnopharmacol 2010, 128:482-489.
69. Kumar B.S., Lee Y.J., Yi H.J., Chung B.C., Jung B.H. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Anal Chim Acta 2010, 661:47-59.
70. Gu H., Pan Z., Xi B., Hainline B.E., Shanaiah N., Asiago V., et al. 1H NMR metabolomics study of age profiling in children. NMR Biomed 2009, 22:826-833.
71. Lee M.S., Jung B.H., Chung B.C., Cho S.H., Kim K.Y., Kwon O.S., et al. Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine. Int J Toxicol 2009, 28:392-404.
72. Sun J., Schnackenberg L.K., Hansen D.K., Beger R.D. Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics. Bioanalysis 2010, 2(2):207-216.
73. Beckwith-Hall B.M., Thompson N.A., Nicholson J.K., Lindon J.C., Holmes E. A metabonomic investigation of hepatotoxicity using diffusion-edited 1H NMR spectroscopy of blood serum. Analyst 2003, 128:814-818.
74. Soga T., Sugimoto M., Honma M., Mori M., Igarashi K., Kashikura K., et al. Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol 2011, 55:896-905.
75. Yang Q., Yang L., Xiong A., Wang R., Wang Z. Metabolomics study of anti-platelet effect of Radix Paeoniae Rubra and Radix Paeoniae Alba by UPLC-MS. Zhongguo Zhong Yao Za Zhi 2011, 36:698-701.
76. Yang Q., Yang L., Xiong A., Lu L., Wang R., Wang Z. Metabolomics study of anti-inflammatory action of Radix Paeoniae Rubra and Radix Paeoniae Alba by ultraperformance liquid chromatography-mass spectrometry. Zhongguo Zhong Yao Za Zhi 2011, 36:694-697.
77. Tiziani S., Lopes V., Günther U.L. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 2009, 11:269-276.
78. Denery J.R., Nunes A.A., Hixon M.S., Dickerson T.J., Janda K.D. Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl Trop Dis 2010, 4(10). pii: e834.
79. Chen J., Zhang X., Cao R., Lu X., Zhao S., Fekete A., et al. Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J Proteome Res 2011, 10:2625-2632.
80. Duggan G., Hittel D.S., Hughey C.C., Weljie A., Vogel H.J., Shearer J. Differentiating short- and long-term effects of diet in the obese mouse using 1H-NMR metabolomics. Diabetes Obes Metab 2011, 10.1111/j.1463-1326.
81. Bathe O.F., Shaykhutdinov R., Kopciuk K., Weljie A.M., McKay A., Sutherland F.R., et al. Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol Biomarkers Prev 2011, 20:140-147.
82. Barba I., de León G., Martín E., Cuevas A., Aguade S., Candell-Riera J., et al. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 2008, 60:27-32.
83. Weljie A.M., Bondareva A., Zang P., Jirik F.R. (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. J Biomol NMR 2011, 49:185-193.
84. Chen C., Shah Y.M., Morimura K., Krausz K.W., Miyazaki M., Richardson T.A., et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 2008, 7:135-147.
85. Blanchet L., Smolinska A., Attali A., Stoop M.P., Ampt K.A., van Aken H., et al. Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics 2011, 12:254.
86. Stoop M.P., Coulier L., Rosenling T., Shi S., Smolinska A.M., Buydens L., et al. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples. Mol Cell Proteomics 2010, 9:2063-2075.
87. Crews B., Wikoff W.R., Patti G.J., Woo H.K., Kalisiak E., Heideker J., et al. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal Chem 2009, 81:8538-8544.
88. Kawashima H., Oguchi M., Ioi H., Amaha M., Yamanaka G., Kashiwagi Y., et al. Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci 2006, 116:927-936.
89. Wuolikainen A., Moritz T., Marklund S.L., Antti H., Andersen P.M. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLoS One 2011, 6:e17947.
90. Kaddurah-Daouk R., Rozen S., Matson W., Han X., Hulette C.M., Burke J.R., et al. Metabolomic changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement 2011, 7:309-317.
91. Blasco H., Corcia P., Moreau C., Veau S., Fournier C., Vourc'h P., et al. 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS One 2010, 5:e13223.
92. van der Ham M., de Koning T.J., Lefeber D., Fleer A., Prinsen B.H., de Sain-van der Velden M.G. Liquid chromatography-tandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:1098-1102.
93. Rosenling T., Slim C.L., Christin C., Coulier L., Shi S., Stoop M.P., et al. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). J Proteome Res 2009, 8:5511-5522.
94. Himmelreich U., Malik R., Kühn T., Daniel H.M., Somorjai R.L., Dolenko B., et al. Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response. PLoS One 2009, 4:e5328.
95. Wikoff W.R., Pendyala G., Siuzdak G., Fox H.S. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest 2008, 118:2661-2669.
96. Giovane A., Balestrieri A., Napoli C. New insights into cardiovascular and lipid metabolomics. J Cell Biochem 2008, 105:648-654.
97. Sugimoto M., Wong D.T., Hirayama A., Soga T., Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010, 6:78-95.
98. Bertram H.C., Eggers N., Eller N. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Anal Chem 2009, 81:9188-9193.
99. Wei J., Xie G., Zhou Z., Shi P., Qiu Y., Zheng X., et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2011, 129:2207-2217.
100. Yan S.K., Wei B.J., Lin Z.Y., Yang Y., Zhou Z.T., Zhang W.D. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol 2008, 44(5):477-483.
101. Moazzami A.A., Andersson R., Kamal-Eldin A. Changes in the metabolic profile of rat liver after α-tocopherol deficiency as revealed by metabolomics analysis. NMR Biomed 2011, 24:499-505.
102. Sun Y., Wang Y.H., Qu K., Zhu H.B. Beneficial effects of cordycepin on metabolic profiles of liver and plasma from hyperlipidemic hamsters. J Asian Nat Prod Res 2011, 13:534-546.
103. Huang Q., Yin P., Wang J., Chen J., Kong H., Lu X., et al. Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879:961-967.
104. Cortés M., Pareja E., Castell J.V., Moya A., Mir J., Lahoz A. Exploring mass spectrometry suitability to examine human liver graft metabonomic profiles. Transplant Proc 2010, 42:2953-2958.
105. Huang C.C., Lin W.T., Hsu F.L., Tsai P.W., Hou C.C. Metabolomics investigation of exercise-modulated changes in metabolism in rat liver after exhaustive and endurance exercises. Eur J Appl Physiol 2010, 108:557-566.
106. Gu S., A J, Wang G., Zha W., Yan B., Zhang Y., et al. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia. Biomed Chromatogr 2010, 24:245-252.
107. Atherton H.J., Gulston M.K., Bailey N.J., Cheng K.K., Zhang W., Clarke K., et al. Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Mol Syst Biol 2009, 5:259.
108. Xu J., Zhang J., Cai S., Dong J., Yang J.Y., Chen Z. Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy. Anal Bioanal Chem 2009, 393:1657-1668.
109. Hwang G.S., Yang J.Y., Ryu do H., Kwon T.H. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics. Am J Physiol Renal Physiol 2010, 298:461-470.
110. Boudonck K.J., Mitchell M.W., Német L., Keresztes L., Nyska A., Shinar D., et al. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 2009, 37:280-292.
111. Liu J.Y., Li N., Yang J., Li N., Qiu H., Ai D., et al. Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc Natl Acad Sci U S A 2010, 107:17017-17022.
112. Suhre K., Shin S.Y., Petersen A.K., Mohney R.P., Meredith D., Wägele B., et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477:54-60.